$PCLA

INVESTOR ALERT: Morris Kandinov LLP Investigating PHH, WAI, PCLA, and EPWK; Stockholders are Encouraged to Contact the Firm - PicoCELA (NASDAQ:PCLA), EPWK Holdings (NASDAQ:EPWK)

SAN DIEGO, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- National law firm Morris Kandinov is investigating potential claims on behalf of victims of pump-and-dump schemes involving the following securities: Park Ha Biological Technology Co., Ltd. PHH. Top KingWin Ltd WAI. PicoCELA Inc.

Original reporting
Benzinga · Globe Newswire
Published Aug 8, 2025, 6:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 8, 2025, 7:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$PCLA
Bearish
medium confidence
Mentioned
$PCLA · $WAI
Relevance
6/10
AlphAI data visualization · based on Benzinga
Decision brief

The 30-second read

$PCLABearishMed
01

Why it matters

Legal scrutiny typically causes short-term declines; however, long-term impact depends on investigation outcomes.

02

Market read

The investigation has immediate relevance to the involved securities, with potential ripple effects in related sectors.

03

What to watch

Potential for regulatory resolution or settlement that could mitigate downside risk.

Relevance 6/10Timing: Immediate to short-term (next 1-4 weeks)

Background

The investigation by Morris Kandinov LLP targets securities allegedly involved in pump-and-dump schemes, raising concerns about market manipulation.

Company-level read

Ticker impact

$PCLABearishMedium confidence
Context

High relevance as it is explicitly mentioned in the investigation and investor alert.

Expected impact

Expected decline of approximately 10% in the near term.

Evidence & confidence

Legal and regulatory scrutiny can negatively impact stock prices; the exact magnitude depends on further news.

$WAIBearishMedium confidence
Context

High relevance due to direct mention in the investigation.

Expected impact

Possible decline of 8-12% in the immediate future.

Evidence & confidence

Market reactions to legal investigations tend to be negative, especially if allegations are serious.

Market effects

Potential negative impact on biotech and financial sectors involved in the investigation.

Limited regional impact, primarily affecting US-based securities.

Low; impact is localized to specific securities and sectors.

Counterpoint

Legal investigations may be a temporary setback; if allegations are unfounded, stocks could recover quickly.

Key entities

  • Morris Kandinov LLP

    Legal firm investigating securities for potential fraud.

  • PHH

    Biotech company under investigation.

  • WAI

    Financial services firm involved in the investigation.

  • PCLA

    Technology company targeted in the probe.

  • EPWK

    Holding company under scrutiny.

Related articles

$PCLALow

PicoCELA Inc. (PCLA): Financial results for H1 2026

PicoCELA Inc. (PCLA) furnished an SEC Form 6-K — earnings release. Exhibit 99.2 MANAGEMENT’S SUPLEMENTAL EXPLANATION ON FINANCIAL RESULTS OF OPERATIONS Operating Results Comparison of the Results for the Six Months Ended March 31, 2026, 2025 and 2024 The following table sets forth statements of operations of PicoCELA Inc., a joint stock corporat

$AMZNMed

Big Tech’s nuclear land grab: Who really pays when data centers devour the grid? – NaturalNews.com

Amazon and Google signed 20-year deals with Constellation Energy for nuclear power, totaling $4.3B. Amazon secured 690 MW from Calvert Cliffs, while Google's deal covers 11 reactors. Critics question if these agreements will meet data center demand and impact household electricity costs. The Energy Department approved $4.4B in loans for nuclear facilities. Meta, Microsoft, and Amazon have also made significant nuclear power agreements.

$BAMed

Boeing 777 freighter output halted for two months over supplier row - Reuters

Boeing (NYSE:BA) halted 777 freighter production for two months due to a supplier dispute with Vaero, costing up to $6.5M daily. The issue also impacted 767 aircraft production. Boeing is bringing manufacturing in-house and has removed two partially assembled 777 freighters from its assembly line. The 777X program is unaffected. Boeing has delivered 21 777 freighters this year, with more possible by 2026.

$MRNAHigh

Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

Moderna and Merck reported late-stage trial results showing their personalized mRNA melanoma vaccine, intismeran, reduced relapse risk by 42% when combined with Keytruda. The trial involved 1,137 patients, with 82% of vaccine recipients showing no recurrence after two years, compared to 70% for the placebo group. The companies plan to present the findings at a medical conference and continue long-term studies.